FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Eptifibatide (Integrilin) Injection
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Merck Sharp & Dohme Corp. (New 11/18/2019)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
0.75 mg/mL (NDCs 0085-1136-02 and 0085-1136-03) 11/18/2019 The following presentation will continue to be available: 0.75 mg/mL (NDC 0085-1136-01 )
2 mg/mL (NDCs 0085-1177-03 and 0085-1177-05) 11/18/2019 The following presentations will continue to be available: 2 mg/mL (NDCs 0085-1177-01 and 0085-1177-02)

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English